You are here » Home » Companies » Company Overview » Godavari Drugs Ltd

Godavari Drugs Ltd.

BSE: 530317 Sector: Health care
NSE: N.A. ISIN Code: INE362C01012
BSE LIVE 19:40 | 19 Oct 43.35 2.00
(4.84%)
OPEN

42.00

HIGH

44.90

LOW

42.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 42.00
PREVIOUS CLOSE 41.35
VOLUME 50392
52-Week high 54.90
52-Week low 32.00
P/E 22.35
Mkt Cap.(Rs cr) 33
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 42.00
CLOSE 41.35
VOLUME 50392
52-Week high 54.90
52-Week low 32.00
P/E 22.35
Mkt Cap.(Rs cr) 33
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Godavari Drugs Ltd. (GODAVARIDRUGS) - Company History

Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.